Interview with Dr. Bruno Steinkraus, Chief Scientific Officer at Hummingbird Diagnostics GmbH
We are very pleased to announce that the EPAD LCS study is now recruiting volunteers in San Sebastian (Spain), which opened as a new EPAD Trial Delivery Center. This centre is the first wave 2 centres opened and few other will be following very soon.
Aranzazu is the first participant enrolled in the EPAD project in San Sebastian. “I volunteered because my father had Alzheimer’s disease and I want to contribute to give the chance to my relatives and the rest of the society to live without this devastating disease”, she said after her first visit. Aranzazu is one of the participants of the CITA Foundation’s Basque Cohort. This site has just initiated enrolment, under the coordination of the National Lead of the project, the Barcelonabeta Brain Research Center.
According to Pablo Martinez-Lage, Scientific Director of the CITA Foundation, “EPAD offers a unique opportunity to take part in the most innovative study and clinical trial for the prevention of Alzheimer’s to those who may be at risk of developing the disease”.
Aranzazu is 71 years old and has been collaborating with CITA since 2010. “After my participation in the Gipuzkoa Alzheimer’s Project, I have to recognise that I am familiar with the tests that I have done. The magnetic resonance, the neuropsychological tests and the rest of the tests are nothing compared to the sense of pride that I feel for my participation in this research project”, she explained.
CITA expects to enrol at least 50 participants who will have regular health checks, including cognitive and genetic tests, brain scans, and lumbar punctures.
The Spanish press release announcing the first participant enrolled in CITA is available here.
Related posts
